Anti-TIF1-Î³ antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer.

Li, Jinjin; Yi, Shouhui; Huang, Yusheng; Peng, Yuan; Yang, Zhenzhou

Li, Jinjin; Yi, Shouhui; Huang, Yusheng; Peng, Yuan; Yang, Zhenzhou.

Afiliação

Li J; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Yi S; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Huang Y; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Peng Y; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. pengyuan1127@cqmu.edu.cn.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, and Chongqing Clinical Research Centre for Geriatrics and Gerontology, Chongqing, China. yangzz@cqmu.edu.cn.

Clin Exp Rheumatol ; 41(2): 395, 2023 03.

Article em En | MEDLINE | ID: mdl-36622123

Assuntos

Anticorpos Monoclonais Humanizados; Dermatomiosite; Neoplasias Esofágicas; Humanos; Anticorpos Monoclonais Humanizados/efeitos adversos; Dermatomiosite/induzido quimicamente; Neoplasias Esofágicas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Dermatomiosite / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google